Literature DB >> 8865001

DNA ploidy and S-phase in recurrent astrocytomas: a retrospective study by flow cytometry of deparaffinized specimens.

L Vavruch1, B Nordenskjöld, J Carstensen, S Eneström.   

Abstract

Twenty-two patients with recurrent astrocytic tumors were treated surgically two or even three times. At the time of the first surgery 6 tumors were fibrillary astrocytomas (grade II), 9 anaplastic astrocytomas (grade III) and 7 glioblastomas (grade IV). Histopathological specimens from second surgery demonstrated in 12 cases signs of higher grades of malignancy. Flow cytometry (FCM) did not reveal any significant changes of S-phase fraction (p = 0.55). This study supports the theory that, given enough time, the histopathology of brain tumors change significantly from more benign forms to more malignant ones. The flow cytometry (FCM) could trace a weak tendency to higher S-phase fractions at the time of the second surgery. No apparent change of ploidy pattern was observed. In spite of the unequivocal histopathological changes of the recurrent astrocytomas the flow cytometry failed to indicate similar changes in terms of ploidy and S-phase fraction parameters.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8865001     DOI: 10.1007/bf00177441

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  28 in total

1.  Prognostic implications of the proliferative potential of low-grade astrocytomas.

Authors:  T Hoshino; L A Rodriguez; K G Cho; K S Lee; C B Wilson; M S Edwards; V A Levin; R L Davis
Journal:  J Neurosurg       Date:  1988-12       Impact factor: 5.115

Review 2.  [Purification kinetics of human tumors measured by flow cytometry].

Authors:  K Goerttler
Journal:  Acta Histochem Suppl       Date:  1990

3.  Correlation of in vitro bromodeoxyuridine labeling index and DNA aneuploidy with survival or recurrence in brain-tumor patients.

Authors:  T Nishizaki; T Orita; K Kajiwara; N Ikeda; N Ohshita; H Nakayama; Y Furutani; Y Ikeyama; T Akimura; T Kamiryo
Journal:  J Neurosurg       Date:  1990-09       Impact factor: 5.115

4.  Correlation of DNA content and histology in prognosis of astrocytomas.

Authors:  S W Coons; J R Davis; D L Way
Journal:  Am J Clin Pathol       Date:  1988-09       Impact factor: 2.493

5.  Flow cytometric analysis of cellular DNA content in human astrocytomas and oligodendrogliomas.

Authors:  A Ahyai
Journal:  Neurosurg Rev       Date:  1988       Impact factor: 3.042

6.  Effect of age and reoperation on survival in the combined modality treatment of malignant astrocytoma.

Authors:  M Salcman; R S Kaplan; T B Ducker; H Abdo; E Montgomery
Journal:  Neurosurgery       Date:  1982-04       Impact factor: 4.654

7.  Comparison of bromodeoxyuridine labeling indices obtained from tissue sections and flow cytometry of brain tumors.

Authors:  T Nagashima; T Hoshino; K G Cho; M Senegor; F Waldman; K Nomura
Journal:  J Neurosurg       Date:  1988-03       Impact factor: 5.115

8.  Relationship between flow cytometric features and clinical behavior of meningiomas.

Authors:  K R Crone; V R Challa; T E Kute; D M Moody; D L Kelly
Journal:  Neurosurgery       Date:  1988-12       Impact factor: 4.654

9.  Comparison of cytologic composition with microfluorometric DNA analysis of the glioblastoma multiforme and anaplastic astrocytoma.

Authors:  F Giangaspero; P Chieco; G Lisignoli; P C Burger
Journal:  Cancer       Date:  1987-07-01       Impact factor: 6.860

10.  p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression.

Authors:  D J van Meyel; D A Ramsay; A G Casson; M Keeney; A F Chambers; J G Cairncross
Journal:  J Natl Cancer Inst       Date:  1994-07-06       Impact factor: 13.506

View more
  3 in total

1.  Radiation change versus recurrent astrocytoma: diagnostic utility of the proliferation index?

Authors:  E H Bigio; S M Colvin; B E Mickey; C L White; E J Rushing
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Cellular DNA content parameters as prognostic indicators in human astrocytomas.

Authors:  Basil F El-Rayes; Camille S Norton; Wael Sakr; Zosia Maciorowski; Daryn Smith; Haline Pietraszkiewicz; Maria Del Mar Alonso; John F Ensley
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

3.  Activities of DNA-PK and Ku86, but not Ku70, may predict sensitivity to cisplatin in human gliomas.

Authors:  Cui-Jie Shao; Jun Fu; Hong-Liu Shi; Yong-Gao Mu; Zhong-Ping Chen
Journal:  J Neurooncol       Date:  2008-04-16       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.